SKKU Researchers Develop World's First Oral Microbiome-Based Nanomedicine to Supercharge Anti-Cancer Immunity

Engineered a DHB prodrug-based oral nano-emulsion with enhanced bioavailability, dramatically improving the efficacy of immune checkpoint blockade therapy